These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27663098)

  • 1. Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart Failure.
    Matsue Y; Ter Maaten JM; Struck J; Metra M; O'Connor CM; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Dittrich HC; van Veldhuisen DJ; van der Meer P; Damman K; Voors AA
    J Card Fail; 2017 Mar; 23(3):231-239. PubMed ID: 27663098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD.
    Schulz CA; Christensson A; Ericson U; Almgren P; Hindy G; Nilsson PM; Struck J; Bergmann A; Melander O; Orho-Melander M
    J Am Soc Nephrol; 2017 Jan; 28(1):291-303. PubMed ID: 27401687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure.
    Emmens JE; Ter Maaten JM; Damman K; van Veldhuisen DJ; de Boer RA; Struck J; Bergmann A; Sama IE; Streng KW; Anker SD; Dickstein K; Lang CC; Metra M; Samani NJ; Ng LL; Voors AA
    Circ Heart Fail; 2019 May; 12(5):e005544. PubMed ID: 31091993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.
    Ng LL; Squire IB; Jones DJL; Cao TH; Chan DCS; Sandhu JK; Quinn PA; Davies JE; Struck J; Hartmann O; Bergmann A; Mebazaa A; Gayat E; Arrigo M; Akiyama E; Sabti Z; Lohrmann J; Twerenbold R; Herrmann T; Schumacher C; Kozhuharov N; Mueller C;
    J Am Coll Cardiol; 2017 Jan; 69(1):56-69. PubMed ID: 28057251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proenkephalin predicts acute kidney injury in cardiac surgery patients.
    Shah KS; Taub P; Patel M; Rehfeldt M; Struck J; Clopton P; Mehta RL; Maisel AS
    Clin Nephrol; 2015 Jan; 83(1):29-35. PubMed ID: 25512100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.
    Smilde TD; Damman K; van der Harst P; Navis G; Westenbrink BD; Voors AA; Boomsma F; van Veldhuisen DJ; Hillege HL
    Clin Res Cardiol; 2009 Feb; 98(2):121-9. PubMed ID: 18979056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study.
    Kieneker LM; Hartmann O; Bergmann A; de Boer RA; Gansevoort RT; Joosten MM; Struck J; Bakker SJL
    Biomarkers; 2018 Jul; 23(5):474-482. PubMed ID: 29466891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study.
    Cleland JG; Chiswell K; Teerlink JR; Stevens S; Fiuzat M; Givertz MM; Davison BA; Mansoor GA; Ponikowski P; Voors AA; Cotter G; Metra M; Massie BM; O'Connor CM
    Circ Heart Fail; 2014 Jan; 7(1):76-87. PubMed ID: 24281134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Usefulness of Proenkephalin in Stable Ambulatory Patients With Heart Failure.
    Arbit B; Marston N; Shah K; Lee EL; Aramin H; Clopton P; Maisel AS
    Am J Cardiol; 2016 Apr; 117(8):1310-4. PubMed ID: 26916537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function trajectories and clinical outcomes in acute heart failure.
    Givertz MM; Postmus D; Hillege HL; Mansoor GA; Massie BM; Davison BA; Ponikowski P; Metra M; Teerlink JR; Cleland JG; Dittrich HC; O'Connor CM; Cotter G; Voors AA
    Circ Heart Fail; 2014 Jan; 7(1):59-67. PubMed ID: 24281137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).
    Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL
    Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
    Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S
    J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Proenkephalin and Poor Long-Term Outcome in Renal Transplant Recipients.
    Kieneker LM; Hartmann O; Struck J; Bergmann A; Gansevoort RT; Joosten MM; van den Berg E; de Boer RA; Bakker SJL
    Transplant Direct; 2017 Aug; 3(8):e190. PubMed ID: 28795142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proenkephalin: A New Biomarker for Glomerular Filtration Rate and Acute Kidney Injury.
    Khorashadi M; Beunders R; Pickkers P; Legrand M
    Nephron; 2020; 144(12):655-661. PubMed ID: 32739920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proenkephalin a 119-159 (penKid) - a novel biomarker for acute kidney injury in sepsis: an observational study.
    Rosenqvist M; Bronton K; Hartmann O; Bergmann A; Struck J; Melander O
    BMC Emerg Med; 2019 Nov; 19(1):75. PubMed ID: 31779591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure.
    Damman K; van der Harst P; Smilde TD; Voors AA; Navis G; van Veldhuisen DJ; Hillege HL
    Heart; 2012 Feb; 98(4):319-24. PubMed ID: 22038544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.